Hanny T Al-Samkari

107PUBLICATIONS
174CO-AUTHORS
Applied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)HaematologyHaematological tumoursCancer therapy (excl. chemotherapy and radiation therapy)Major global burdens of disease
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (107)

|Aug 16, 2026
Effect of efgartigimod IV on immature platelet fraction in primary immune thrombocytopenia in the ADVANCE IV trial.

|Aug 04, 2026
Systemic Bevacizumab for Severe Bleeding From Acquired Gastrointestinal Vascular Malformations.

|Jul 13, 2026
Avatrombopag Versus Placebo for Persistent Chemotherapy-Induced Thrombocytopenia in GI Cancers: The Phase II ACT-GI Trial.

|Jul 06, 2026
How I treat chemotherapy-induced thrombocytopenia with thrombopoietin receptor agonists.

|Jun 08, 2026
A call to action for the use of composite hematologic measurements in hereditary hemorrhagic telangiectasia and other chronic bleeding disorders.

|Mar 17, 2026
Clinical spectrum of hereditary hemorrhagic telangiectasia: data from the Comprehensive HHT Outcomes Registry of the US (CHORUS).

Hanny Al-Samkari, Cassi Friday, Raj S Kasthuri

Pageof 18

Frequent Collaborators

10 joint publications

Rachael F Grace

9 joint publications

Andrew Song

6 joint publications

Kevin H M Kuo

6 joint publications

Vivek N Iyer